{
    "patient": {
        "Name": "Jose Petty",
        "DateOfBirth": "1969-10-10",
        "Sex": "Male",
        "Diagnosis": "Acute lymphocytic leukemia (ALL)",
        "BodyPart": "Leukemia",
        "Physician": "Dr. Carla Bird",
        "TreatingInstitution": "Lee-Ramirez"
    },
    "specimen": {
        "Tumor specimen": {
            "source": "Leukemia",
            "CollectedDate": "2023-08-10",
            "ReceivedDate": "2023-08-13",
            "TumorPercentage": "37%"
        },
        "Normal specimen": {
            "source": "Blood",
            "CollectedDate": "2023-08-12",
            "ReceivedDate": "2023-08-13"
        }
    },
    "genomic variants": {
        "Somatic - Potentially Actionable": [
            {
                "Gene": "PRKCA",
                "DNA Alteration": "c.1387G>C",
                "GeneMutation": "p.D463H Spliceregionvariant-GOF",
                "VariantAlleleFraction": "24.12%"
            },
            {
                "Gene": "JAK2",
                "DNA Alteration": "c.2792A>G",
                "GeneMutation": "p.M929I Nonsense-GOF",
                "VariantAlleleFraction": "27.28%"
            }
        ],
        "Somatic - Biologically Relevant": [
            {
                "Gene": "FGFR1",
                "DNA Alteration": "c.1966A>G",
                "GeneMutation": "p.K656E Nonsense-GOF",
                "VariantAlleleFraction": "25.83%"
            }
        ],
        "Germline - Pathogenic": [],
        "Pertinent Negatives": [
            "FGFR2",
            "IDH1",
            "TOP2A"
        ]
    },
    "immunotherapy markers": [
        {
            "marker_name": "Tumor Mutational Burden",
            "TmbValue": "9 m/Mb",
            "Tmbpercentile": "5%",
            "Status type": "Microsatellite Instability Status",
            "statusvalue": "Stable"
        }
    ],
    "FDA-Approved Therapies": {
        "Current Diagnosis": [
            {
                "Mechanism": "KRAS G12C Inhibitors",
                "Medication": "Sotorasib",
                "Recommendations": [
                    "NCCN, Consensus, Non-Small Cell Lung Cancer",
                    "MSK OncoKB, Level 1"
                ],
                "Relevant Mutation": "KRASp.G12C G12C-GOF"
            }
        ],
        "Other Indications": [
            {
                "Mechanism": "KRAS G12C Inhibitors",
                "Medication": "Sotorasib",
                "Recommendations": [
                    "NCCN, Consensus, Non-Small Cell Lung Cancer",
                    "MSK OncoKB, Level 1"
                ],
                "Relevant Mutation": "KRASp.G12C G12C-GOF"
            }
        ]
    }
}